Literature DB >> 6539274

Susceptibilities of drugs to nitrosation under standardized chemical conditions.

P N Gillatt, R J Hart, C L Walters, P I Reed.   

Abstract

Of 22 drugs with either a N,N-dimethylamino, N,N-diethylamino or N-morpholino group in the molecule, eight were converted to volatile N-nitrosamines by nitrosative cleavage in reactions of nitrite and drug in a molar ratio of 4:1 at pH 3. Under standardized conditions yields were greatest with aminopyrine and minocycline which contains two N,N-dimethylamino groups in the molecule. Oxytetracycline, chlortetracycline, tetracycline, promethazine, chlorpromazine, imipramine and disulfiram gave much lower yields and amitriptyline, clomiphene, clomipramine, dextropropoxyphene, diphenhydramine, disopyramide, erythromycin, mepyramine, methapyrilene, penicillin G procaine salt, procaine, tamoxifen, trimeprazine and tripelennamine yielded no detectable levels of volatile N-nitrosamines. Nitrosation products of 57 drugs were also examined by a group selective procedure estimating both volatile and non-volatile N-nitroso compounds. Virtually all of the yield obtained from aminopyrine or minocycline could be accounted for by N-nitrosodimethylamine (NDMA). However, compounds yielding excess N-nitrosamines compared to NDMA were obtained from the other three tetracyclines, presumably as a result of the cleavage of a methyl group from the N,N-dimethylamino substituent to form desmethyl-N-nitroso compounds. In general, the drugs giving the highest yields of N-nitroso compounds were those containing secondary rather than tertiary amino groups. A considerable range of susceptibilities towards nitrous acid was observed overall; ten drugs containing a secondary or tertiary amino- or amido- or hydrazido - group did not react with nitrous acid to form N-nitroso compounds.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539274     DOI: 10.1016/0278-6915(84)90005-x

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  4 in total

1.  Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations.

Authors:  Jean D Brender; Martha M Werler; Mayura U Shinde; Ann M Vuong; Katherine E Kelley; John C Huber; Joseph R Sharkey; John S Griesenbeck; Paul A Romitti; Sadia Malik; Lucina Suarez; Peter H Langlois; Mark A Canfield
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-08-18

2.  Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects.

Authors:  Mayura U Shinde; Ann M Vuong; Jean D Brender; Martha M Werler; Katherine E Kelley; John C Huber; Joseph R Sharkey; Qi Zheng; Lucina Suarez; Peter H Langlois; Mark A Canfield; Paul A Romitti; Sadia Malik
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-05-28

3.  Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy.

Authors:  Jean D Brender; Katherine E Kelley; Martha M Werler; Peter H Langlois; Lucina Suarez; Mark A Canfield
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-04-06

4.  In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions.

Authors:  Zongming Gao; Michael Karfunkle; Wei Ye; Tim Andres Marzan; Jingyue Yang; Timothy Lex; Cynthia Sommers; Jason D Rodriguez; Xiaomei Han; Jeffry Florian; David G Strauss; David A Keire
Journal:  JAMA Netw Open       Date:  2021-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.